169 related articles for article (PubMed ID: 12654917)
1. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.
Jallepalli PV; Lengauer C; Vogelstein B; Bunz F
J Biol Chem; 2003 Jun; 278(23):20475-9. PubMed ID: 12654917
[TBL] [Abstract][Full Text] [Related]
2. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
[TBL] [Abstract][Full Text] [Related]
3. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response.
Ahn J; Urist M; Prives C
J Biol Chem; 2003 Jun; 278(23):20480-9. PubMed ID: 12654916
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
Yu Q; Rose JH; Zhang H; Pommier Y
FEBS Lett; 2001 Sep; 505(1):7-12. PubMed ID: 11557032
[TBL] [Abstract][Full Text] [Related]
5. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
[TBL] [Abstract][Full Text] [Related]
6. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
8. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
Carrassa L; Broggini M; Erba E; Damia G
Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific regulation of checkpoint kinase 2 expression by p53.
Chin MY; Li G
Exp Mol Pathol; 2003 Oct; 75(2):131-6. PubMed ID: 14516774
[TBL] [Abstract][Full Text] [Related]
10. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
Pan Y; Ren KH; He HW; Shao RG
Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
[TBL] [Abstract][Full Text] [Related]
12. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
Rainey MD; Black EJ; Zachos G; Gillespie DA
Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
[TBL] [Abstract][Full Text] [Related]
13. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
14. DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.
Freiberg RA; Hammond EM; Dorie MJ; Welford SM; Giaccia AJ
Mol Cell Biol; 2006 Mar; 26(5):1598-609. PubMed ID: 16478982
[TBL] [Abstract][Full Text] [Related]
15. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
[TBL] [Abstract][Full Text] [Related]
16. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
Chehab NH; Malikzay A; Appel M; Halazonetis TD
Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
[TBL] [Abstract][Full Text] [Related]
17. 53BP1, a mediator of the DNA damage checkpoint.
Wang B; Matsuoka S; Carpenter PB; Elledge SJ
Science; 2002 Nov; 298(5597):1435-8. PubMed ID: 12364621
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
[TBL] [Abstract][Full Text] [Related]
19. p53 down-regulates CHK1 through p21 and the retinoblastoma protein.
Gottifredi V; Karni-Schmidt O; Shieh SS; Prives C
Mol Cell Biol; 2001 Feb; 21(4):1066-76. PubMed ID: 11158294
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
